QC
CLMT icon

Quantessence Capital’s Calumet Specialty Products CLMT Stock Holding History

Quantessence Capital’s Portfolio CLMT Stock Details CLMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-44,436
Closed -$563K – 233
2025
Q1 		$563K Buy
+44,436
New +$698K 0.14% 177

Other funds holding CLMT

WDOM
Wasserstein Debt Opportunities Management New York $189M AUM 169.75% 1-Year Est. Return
AAA
Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
DMKJ
David M. Knott Jr $168M AUM 60.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
GECH
Garnet Equity Capital Holdings New York $642M AUM 58.94% 1-Year Est. Return

Quantessence Capital's CLMT Position: Q2 2025 in Review

Quantessence Capital sold out of Calumet Specialty Products (CLMT) in Q2 2025, closing a stake of 44,436 shares — an estimated $563K sold.

Quantessence Capital first reported a position in CLMT in Q1 2025 and held it in 1 quarter. The position peaked at $563K in Q1 2025. 134 funds tracked by Wall St. Rank hold CLMT as of Q2 2025.

  • Quantessence Capital reported no remaining Calumet Specialty Products position as of Q2 2025 after selling out during the quarter.
  • Quantessence Capital sold 44,436 Calumet Specialty Products shares in Q2 2025, an estimated $563K.
  • Quantessence Capital first reported a position in Calumet Specialty Products in Q1 2025 and held it in 1 quarter.
  • Quantessence Capital's Calumet Specialty Products position peaked at $563K in Q1 2025.
  • 134 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q2 2025.

Based on Quantessence Capital's 13F filing for Q2 2025, filed 14 Aug 2025.